Article
Assessment of TANK-binding kinase 1 as a therapeutic target in cancer
7 Dec 2017
Abstract excerpt
TANK-binding kinase 1 (TBK1) is central to multiple biological processes that promote tumorigenesis including cell division, autophagy, innate immune response and AKT-pro survival signaling. TBK1 is well studied and most known for its function in innate immunity. However, the serine threonine protein kinase received significant attention as a synthetic lethal partner and effector of the major oncogene, RAS. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
